Pflug Koory’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
VCM
N
Pflug Koory's REGN Position: Q1 2026 in Review
Pflug Koory held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2026 at 994 shares worth $768K. The position accounts for 0.35% of the portfolio, ranked #68.
Pflug Koory first reported a position in REGN in Q4 2019 and has held it in 25 quarters since. The position peaked at $1.1M in Q3 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Pflug Koory held 994 shares of Regeneron Pharmaceuticals worth $768K as of Q1 2026.
- Pflug Koory left its Regeneron Pharmaceuticals share count unchanged in Q1 2026.
- Regeneron Pharmaceuticals made up 0.35% of Pflug Koory's portfolio in Q1 2026, its #68 holding.
- Pflug Koory first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 25 quarters since.
- Pflug Koory's Regeneron Pharmaceuticals position peaked at $1.1M in Q3 2024.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Pflug Koory's 13F filing for Q1 2026, filed 22 Apr 2026.